Beta Drugs Balance Sheet Annual

BSE: - | NSE: BETA | ISIN: INE351Y01019 | Sector: Biotechnology & Drugs

1,678.70 -165.60 (-8.98%)Updated : 13 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	495.80	436.23	254.10	198.42
Accumulated Depreciation Total	-69.95	-54.61	-43.30	-35.71
Other Liabilities Total	9.56	9.39	6.27	5.55
Accrued Expenses	0.01	0.01	-	-
Long Term Debt	133.32	126.99	6.04	6.97
Common Stock Total	10.14	10.09	9.61	9.61
Other Current Assets Total	0.01	0.00	0.00	0.58
Prepaid Expenses	1.07	1.01	0.52	0.33
Total Assets	495.80	436.23	254.10	198.42
Current Portof LT Debt/ Capital Leases	6.77	5.35	3.71	4.29
Additional Paid- In Capital	30.43	23.47	23.94	23.94
Cash	3.03	16.88	8.74	4.92
Total Equity	244.77	197.10	157.12	122.88
Retained Earnings( Accumulated Deficit)	204.20	163.53	123.56	89.33
Total Common Shares Outstanding	1.01	1.01	1.01	1.01
Property/ Plant/ Equipment Total- Gross	185.32	134.97	102.37	93.81
Tangible Book Valueper Share Common Eq	231.70	186.76	150.31	117.12
Goodwill Net	2.75	2.75	2.75	2.75
Total Liabilities	251.03	239.14	96.98	75.54
Total Debt	148.19	138.06	14.71	20.33
Short Term Investments	121.82	130.14	19.89	14.24
Cashand Short Term Investments	124.85	147.02	28.63	19.16
Total Receivables Net	120.07	107.19	92.32	71.42
Notes Payable/ Short Term Debt	8.10	5.71	4.96	9.07
Accounts Receivable- Trade Net	119.13	103.08	79.24	62.72
Property/ Plant/ Equipment Total- Net	115.37	80.36	59.20	58.09
Total Current Liabilities	108.14	102.76	84.67	63.02
Total Inventory	89.16	65.16	56.39	36.20
Accounts Payable	80.63	71.28	59.27	40.24
Other Currentliabilities Total	12.63	20.41	16.73	9.42
Total Long Term Debt	133.32	126.99	6.04	6.97
Intangibles Net	7.15	5.83	2.64	1.92
Other Long Term Assets Total	17.42	12.77	1.47	1.25
Note Receivable- Long Term	17.96	14.14	10.17	5.95
period Length	0.00	0.00	0.00	0.00
Total Current Assets	335.16	320.39	177.87	127.68
Long Term Investments	-	-	0.00	0.78
Other Equity Total	-	-	-	0.00
Deferred Income Tax	-	-	-	0.00